The F statistic for all instrument variants was over 74, indicating no bias from weak instruments (Supplementary Table S3)
With tirzepatide treatment options, patients gain consistent oversight that builds confidence
Scientists think this could help people who have tummy troubles that just won't go away
"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes" in The New England Journal of Medicine, vol
Introduction Anthem Blue Cross Blue Shield covers GLP-1 medications for some members in 2026, but coverage varies wildly by plan, state, and pharmacy benefit manager
In addition, this medication shows potential in addressing weight-related complication by promoting significant weight loss in individuals struggling with obesity